Table 1. Average Values of Study Measures within the Study Population.
Table 1 outlines the average values of the various measures investigated in this study. Five broad columns are represented in this table. The first broad column lists the particular measures identified in the study. The second, third and fourth broad columns include data on mean, standard deviation, and number of subjects for each of the variables of interest within the respective group. The second broad column lists the value for the particular measure averaged across the study participants who have not met the overall criteria for metabolic syndrome (Metabolic syndrome). The third broad column lists the value for the particular measure averaged across the study participants who have met the overall criteria for metabolic syndrome (Metabolic syndrome). The fourth broad column lists the value for the particular measure averaged across the entire study population. The fifth broad column provides results from statistical comparisons (Mann Whitney U testing for all variables with the exception of TNF-α where the Student’s T-Test was used) between those participants receiving AAP treatment and those not receiving AAP treatment. Significance reported for p < 0.05. Trend towards significance reported for 1.0 > p > 0.05.
| Study Measures | No Metabolic Syndrome | Metabolic Syndrome | Total Study Population | Statistical Comparison (Metabolic Syndrome vs. No Metabolic Syndrome) |
|---|---|---|---|---|
| Mean +/− SD | Mean+/− SD | Mean+/− SD | ||
| Age (years) | 42.5 +/− 12.3 (n= 73) | 46.8 +/− 11.2 (n= 26) | 43.7 +/− 12.1 (n= 99) | p > 0.10 |
| Age at Diagnosis (years) | 30.4 +/− 11.3 (n= 73) | 33.0 +/− 11.6 (n= 26) | 31.0 +/− 11.4 (n= 99) | p > 0.10 |
| Number of Hospitalizations | 3.9 +/− 5.0 (n= 73) | 4.8 +/− 4.1 (n= 26) | 4.2 +/− 4.8 (n= 99) | P > 0.10 |
| Average Duration of Hospitalization (months) | 0.4 +/− 0.8 (n= 73) | 0.8 +/− 1.4 (n= 26) | 0.5 +/− 1.0 (n= 99) | Test Statistic = 1.8, p = 0.066 (trend towards significance) |
| TNF-α (pg/ml) | 8.9 +/− 2.4 (n= 70) | 9.9 +/− 2.0 (n= 26) | 9.2 +/− 2.3 (n= 96) | T94 = 2.0, p = 0.05 (trend towards significance) |
| Systolic Blood Pressure (mm Hg) | 119.5 +/− 15.4 (n= 72) | 134.0 +/− 20.0 (n= 26) | 123.0 +/− 18.0 (n= 98) | Test Statistic = 3.7, p < 0.001 (significant) |
| Diastolic Blood Pressure (mm Hg) | 72.6 +/− 11.7 (n= 72) | 76.0 +/− 10.1 (n= 26) | 73.0 +/− 11.0 (n= 98) | p > 0.10 |
| Waist Circumference (cm) | 99.0 +/− 18.0 (n= 70) | 112.0 +/− 9.8 (n= 26) | 102.5 +/− 17.2 (n= 96) | Test Statistic = 3.5, p = 0.001 (significant) |
| HDL (mg/dl) | 62.1 +/− 15.7 (n= 70) | 48.0 +/− 10.0 (n= 26) | 58.3 +/− 15.7 (n= 96) | Test Statistic = −4.4, p < 0.001 (significant) |
| Triglycerides (mg/dl) | 111.0 +/− 89.3 (n= 70) | 234.3 +/− 102.9 (n= 26) | 144.4 +/− 107.7 (n= 96) | Test Statistic = 5.6, p < 0.001 (significant) |
| Total Cholesterol (mg/dl) | 181.6 +/− 35.3 (n= 70) | 216.5 +/− 62.6 (n= 26) | 191.0 +/− 46.7 (n= 96) | Test Statistic = 2.5, p = 0.01 (significant) |
| Fasting Glucose (mg/dl) | 95.5 +/− 16.5 (n= 69) | 114.7 +/− 36.4 (n= 25) | 100.6 +/− 24.8 (n= 94) | Test Statistic = 3.7, p < 0.001 (significant) |